Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Two new compounds were found to effectively reduce hair growth in mice.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

Carpronium chloride increases blood flow by widening small blood vessels.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Minoxidil might partially activate estrogen receptors, affecting hair growth.

Minoxidil can reduce functions related to androgen receptors.

The study explains how minoxidil sulfate causes vasodilation in rabbits by opening potassium channels and inhibiting calcium channels.

Carthamus oxyacantha may help treat BPH by inhibiting 5α-reductase.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Hydralazine and minoxidil are blood pressure medications that relax blood vessels, with potential side effects like rapid heartbeat and fluid retention, and are used for severe or pregnancy-related hypertension.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Chloroquine and cinchonine relax rat blood vessels by affecting calcium channels, with chloroquine needing caution in heart patients.

High doses of minoxidil can harm marmoset hearts and kidneys, possibly affecting humans similarly.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Maslinic acid from olive extracts promotes hair growth like minoxidil.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Minoxidil helps control blood pressure but has side-effects, so it's not for everyone.

BMS-470539 reduces skin fibrosis and inflammation.